Table 1

PICOTS system for predictive models

PopulationAdult ambulatory patients with pancreatic, gastric or oesophageal cancer receiving one or more of the treatment options including systemic chemotherapy, radiation therapy, immunotherapy and targeted therapy
InterventionUse of internally/externally validated predictive models for VTE
ComparatorNo predefined comparator. However, models will be compared with each other
Outcome to be predictedVenous thromboembolism within 12 months from the cancer diagnosis
Follow-up period12 months from diagnosis of cancer
SettingModels used in ambulatory settings
  • VTE, venous thromboembolism.